Cargando…
Potential Therapeutic Role of Pituitary Adenylate Cyclase-Activating Polypeptide for Dry Eye Disease
Dry eye disease (DED) is caused by a reduction in the volume or quality of tears. The prevalence of DED is estimated to be 100 million in the developed world. As aging is a risk factor for DED, the prevalence of DED is expected to grow at a rapid pace in aging populations, thus creating an increased...
Autores principales: | Hirabayashi, Takahiro, Shibato, Junko, Kimura, Ai, Yamashita, Michio, Takenoya, Fumiko, Shioda, Seiji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775530/ https://www.ncbi.nlm.nih.gov/pubmed/35054857 http://dx.doi.org/10.3390/ijms23020664 |
Ejemplares similares
-
Molecular Mechanism for PACAP 38-Induced Neurite Outgrowth in PC12 Cells
por: Shibato, Junko, et al.
Publicado: (2021) -
Distribution and protective function of pituitary adenylate cyclase-activating polypeptide in the retina
por: Nakamachi, Tomoya, et al.
Publicado: (2012) -
Molecular and Physiological Functions of PACAP in Sweat Secretion
por: Yamashita, Michio, et al.
Publicado: (2023) -
Pituitary adenylate cyclase activating polypeptide and migraine
por: Zagami, Alessandro S, et al.
Publicado: (2014) -
Pituitary Adenylate Cyclase-Activating Polypeptide in Learning and Memory
por: Gilmartin, Marieke R., et al.
Publicado: (2021)